Przejdź do zawartości
Merck

Przejdź do

MAB9013

Anti-Coronavirus Group Antigen Antibody, nucleoprotein of OC-43, clone 542-7D

clone 542-7D, Chemicon®, from mouse

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
100 μg

Dostępne do wysyłki DZISIAJzKuehne + Nagel Sp. z o.o.

1320,00 zł

Informacje o tej pozycji

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
542-7D, monoclonal
Species reactivity:
human
Application:
IF
Citations:
42

1320,00 zł


Dostępne do wysyłki DZISIAJSzczegóły


Zamów zamówienie zbiorcze
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

mouse

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

542-7D, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG

shipped in

wet ice

Immunogen

Epitope: nucleoprotein of OC-43.

Application

Anti-Coronavirus Group Antigen Antibody, nucleoprotein of OC-43, clone 542-7D detects level of Coronavirus Group Antigen & has been published & validated for use in IF.
IFA. Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Coronavirus nucleoprotein; Strain OC-43

Physical form

Format: Purified
Purified Immunoglobulin. Supplied in PBS buffer pH 7.4. Contains 0.1% sodium azide and carrier protein.

Preparation Note

Maintain at +4°C for up to 12 months. Avoid repeated freeze/thaw cycles.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
MAB9012MAB8258BMAB8258
clone

542-7D, monoclonal

clone

541-8F, monoclonal

clone

A3, monoclonal

clone

A3, monoclonal

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable


Still not finding the right product?

Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.


Klasa składowania

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów



Daniel Poston et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(5), e1208-e1211 (2020-12-04)
Cross-reactive immune responses elicited by seasonal coronaviruses might affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in prepandemic sera from patients with prior polymerase chain reaction scan-confirmed seasonal coronavirus infection.
Kentaro Uemura et al.
iScience, 24(10), 103120-103120 (2021-09-21)
Newly emerging or re-emerging viral infections continue to cause significant morbidity and mortality every year worldwide, resulting in serious effects on both health and the global economy. Despite significant drug discovery research against dengue viruses (DENVs) and severe acute respiratory
Ryohei Hirose et al.
mSphere, 6(3) (2021-05-14)
Human coronavirus (HCoV)-OC43 rarely shows a cytopathic effect (CPE) after infection of various cell lines, and the indirect immunoperoxidase assay (IPA), a relatively complex procedure, has long been used as an alternative assay. Because HCoV-OC43 uses cell-surface transmembrane protease serine



Numer pozycji handlu globalnego

SKUNUMER GTIN
MAB901304053252617348

Questions

Reviews

No rating value

Active Filters